Untitled

Loading Events

« All Webinars

On-demand CE programs From the FDA’s Division of Drug Information

The U.S. Food and Drug Administration’s (FDA) Division of Drug Information* presents… Educational Webinars for Healthcare Professionals

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) sponsors a series of educational webinars targeting the needs of healthcare professionals and students. The webinars cover a broad range of FDA drug regulation and medication safety topics. These focused webinars support FDA’s mission of promoting and protecting public health through interaction and education to strengthen current and future partnerships and relationships with clinicians and researchers.

Home Study CE Webinar Topics include:

Past Home Study CE Webinar Topics from the Center for Drug Evaluation and Research (CDER) delivered in 2020 include:

Target Audience: The target audience for these courses is healthcare professionals, including physicians, physician assistants, nurses, nurse practitioners, pharmacists, and pharmacy technicians. The courses can be taken for informational purposes or for Continuing Education (CE) credit.

Continuing Education: CE credit is available for the FDA’s live and home study webinars. If you are a physician, physician assistant, nurse, pharmacist, or pharmacy technician, refer to the individual webinar listing for complete CME/AAPA/CNE/CPE/CPT/CPH information. Note:  To receive your certificate for CE credit, you must complete the post-test and receive a score of 80% or better and complete an evaluation form. Other users may complete evaluation and print a Certificate of Completion.

*NOTE: This is an industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.

For questions about content or about technical issues, contact FDA: (855) 543-3784, or (301) 796-3400; Email: DDIWebinars@fda.hhs.gov. Online at http://www.fda.gov/AboutDDI